Kling Biotherapeutics to Present Discoveries on its Primary B-Cell Screening Platform at the ESMO Targeted Anticancer Therapies Congress finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Kling Bio ("Kling" or "the Company"), a biotech company developing antibody-based drugs against targets identified from its immortalized B-cell.
/PRNewswire/ Kling Biotherapeutics, B.V., a clinical-stage company pioneering the discovery and development of novel antibody-based therapeutics, today.
Time BioVentures Launches $100M Fund - Los Angeles Business Journal labusinessjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labusinessjournal.com Daily Mail and Mail on Sunday newspapers.